Authors:
Furman, PA
Jeffrey, J
Keifer, LL
Feng, JY
Anderson, KS
Borroto-Esoda, K
Hill, E
Copeland, WC
Chu, CK
Sommadossi, JP
Liberman, I
Schinazi, RF
Painter, GR
Citation: Pa. Furman et al., Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine, ANTIM AG CH, 45(1), 2001, pp. 158-165
Citation: Gr. Painter et al., Conformation and local environment of nucleotides bound to HIV type 1 reverse transcriptase (HIV-1 RT) in the ground state, NUCLEOS NUC, 19(1-2), 2000, pp. 13-29
Citation: Pa. Furman et al., An analysis of the catalytic cycle of HIV-1 reverse transcriptase: Opportunities for chemotherapeutic intervention based on enzyme inhibition, CUR PHARM D, 6(5), 2000, pp. 547-567
Authors:
Elion, GB
Furman, PA
Fyfe, JA
de Miranda, P
Beauchamp, L
Schaeffer, HJ
Fiddian, AP
Citation: Gb. Elion et al., The selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine, REV MED VIR, 9(3), 1999, pp. 147-147
Authors:
Elion, GB
Furman, PA
Fyfe, JA
de Miranda, P
Beauchamp, L
Schaeffer, HJ
Citation: Gb. Elion et al., Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine (Reprinted from Proc. Natl Acad. Sci. USA, vol 74, pg 5716-5720, 1977), REV MED VIR, 9(3), 1999, pp. 148-152
Citation: Pa. Furman et Rf. Schinazi, The mechanism of action and cellular pharmacology of anti-hepatitis B virus agents, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 273-283